SCHEMBL18734926

SCHEMBL18734926

CCC(=O)NC(CSC(=O)CC(=O)C(=O)OC(C)C)C(=O)N(CC)CC

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18734934 0.89 — —
SCHEMBL18734936 0.88 ALOX15 (0.31) ALOX15
SCHEMBL18735180 0.88 ALOX15 (0.32) ALOX15
SCHEMBL18734935 0.86 KMT2A (0.32) —
SCHEMBL18734927 0.86 ALOX15 (0.32) ALOX15
SCHEMBL18735109 0.84 CYP2C9 (0.34) —
SCHEMBL18735399 0.84 CYP2C9 (0.34) —
SCHEMBL18735352 0.82 KMT2A (0.38) ALOX15
SCHEMBL18735186 0.81 CYP2C9 (0.30) —
SCHEMBL18734967 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback